Bio-Rad Laboratories Other Long-Term Assets 2010-2025 | BIO
Bio-Rad Laboratories other long-term assets from 2010 to 2025. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Bio-Rad Laboratories other long-term assets for the quarter ending March 31, 2025 were $0.104B, a 11.66% increase year-over-year.
- Bio-Rad Laboratories other long-term assets for 2024 were $0.102B, a 7.38% increase from 2023.
- Bio-Rad Laboratories other long-term assets for 2023 were $0.095B, a 0.32% increase from 2022.
- Bio-Rad Laboratories other long-term assets for 2022 were $0.095B, a 9.2% decline from 2021.
| Bio-Rad Laboratories Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $102 |
| 2023 | $95 |
| 2022 | $95 |
| 2021 | $104 |
| 2020 | $87 |
| 2019 | $80 |
| 2018 | $70 |
| 2017 | $95 |
| 2016 | $48 |
| 2015 | $65 |
| 2014 | $52 |
| 2013 | $55 |
| 2012 | $40 |
| 2011 | $210 |
| 2010 | $173 |
| 2009 | $125 |
| Bio-Rad Laboratories Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $104 |
| 2024-12-31 | $102 |
| 2024-09-30 | $104 |
| 2024-06-30 | $98 |
| 2024-03-31 | $93 |
| 2023-12-31 | $95 |
| 2023-09-30 | $98 |
| 2023-06-30 | $100 |
| 2023-03-31 | $96 |
| 2022-12-31 | $95 |
| 2022-09-30 | $102 |
| 2022-06-30 | $101 |
| 2022-03-31 | $104 |
| 2021-12-31 | $104 |
| 2021-09-30 | $107 |
| 2021-06-30 | $99 |
| 2021-03-31 | $92 |
| 2020-12-31 | $87 |
| 2020-09-30 | $82 |
| 2020-06-30 | $80 |
| 2020-03-31 | $78 |
| 2019-12-31 | $80 |
| 2019-09-30 | $73 |
| 2019-06-30 | $64 |
| 2019-03-31 | $65 |
| 2018-12-31 | $70 |
| 2018-09-30 | $73 |
| 2018-06-30 | $75 |
| 2018-03-31 | $78 |
| 2017-12-31 | $95 |
| 2017-09-30 | $58 |
| 2017-06-30 | $58 |
| 2017-03-31 | $53 |
| 2016-12-31 | $48 |
| 2016-09-30 | $64 |
| 2016-06-30 | $65 |
| 2016-03-31 | $66 |
| 2015-12-31 | $65 |
| 2015-09-30 | $46 |
| 2015-06-30 | $50 |
| 2015-03-31 | $49 |
| 2014-12-31 | $52 |
| 2014-09-30 | $50 |
| 2014-06-30 | $49 |
| 2014-03-31 | $46 |
| 2013-12-31 | $55 |
| 2013-09-30 | $36 |
| 2013-06-30 | $382 |
| 2013-03-31 | $380 |
| 2012-12-31 | $40 |
| 2012-09-30 | $301 |
| 2012-06-30 | $270 |
| 2012-03-31 | $263 |
| 2011-12-31 | $210 |
| 2011-09-30 | $202 |
| 2011-06-30 | $212 |
| 2011-03-31 | $206 |
| 2010-12-31 | $173 |
| 2010-09-30 | $151 |
| 2010-06-30 | $136 |
| 2010-03-31 | $142 |
| 2009-12-31 | $125 |
| 2009-09-30 | $125 |
| 2009-06-30 | $112 |
| 2009-03-31 | $92 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.175B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.407B | 27.95 |
| Boston Scientific (BSX) | United States | $155.727B | 38.99 |
| Stryker (SYK) | United States | $146.049B | 30.54 |
| EssilorLuxottica (ESLOY) | France | $127.608B | 0.00 |
| Medtronic (MDT) | Ireland | $106.425B | 15.09 |
| Haleon (HLN) | United Kingdom | $51.105B | 29.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.009B | 0.00 |
| ResMed (RMD) | United States | $35.893B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.299B | 15.34 |
| Agilent Technologies (A) | United States | $31.909B | 20.73 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Insulet (PODD) | United States | $22.874B | 89.79 |
| Koninklijke Philips (PHG) | Netherlands | $21.656B | 15.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.236B | 11.71 |
| Baxter (BAX) | United States | $15.652B | 11.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.683B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.228B | 13.19 |
| Prestige Consumer Healthcare (PBH) | United States | $4.233B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.680B | 9.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.319B | 24.48 |
| Haemonetics (HAE) | United States | $3.253B | 14.82 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| GN Store Nord (GNNDY) | Denmark | $2.224B | 18.42 |
| QuidelOrtho (QDEL) | United States | $2.074B | 14.27 |
| LeMaitre Vascular (LMAT) | United States | $1.857B | 41.51 |
| AtriCure (ATRC) | United States | $1.711B | 0.00 |
| Acuren (TIC) | United States | $1.276B | 0.00 |
| Neogen (NEOG) | United States | $1.272B | 16.28 |
| AdaptHealth (AHCO) | United States | $1.212B | 12.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.156B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.109B | 24.95 |
| BioLife Solutions (BLFS) | United States | $1.039B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.990B | 12.65 |
| InMode (INMD) | Israel | $0.927B | 9.34 |
| CeriBell (CBLL) | United States | $0.608B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Owens & Minor (OMI) | United States | $0.510B | 4.23 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.428B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.62 |
| Aurora Cannabis (ACB) | Canada | $0.298B | 53.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.17 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| ZimVie (ZIMV) | United States | $0.255B | 11.57 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.243B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.229B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Quanterix (QTRX) | United States | $0.202B | 0.00 |
| Brainsway (BWAY) | Israel | $0.193B | 51.00 |
| Biote (BTMD) | United States | $0.189B | 5.32 |
| TriSalus Life Sciences (TLSI) | United States | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.137B | 0.00 |
| Jin Medical (ZJYL) | China | $0.118B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Agape ATP (ATPC) | $0.087B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.071B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.029B | 38.86 |
| Safety Shot (SHOT) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |